title: Anticoagulation therapy. Optimal dosages and genotypes for edoxaban therapy.
authors.forename: Karina
authors.initials: K
authors.lastname: Huynh
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000235:genetics*; D065427:Factor Xa Inhibitors / Q000008:administration & dosage* / Q000627:therapeutic use*; D006801:Humans; D011725:Pyridines / Q000008:administration & dosage* / Q000627:therapeutic use*; D013844:Thiazoles / Q000008:administration & dosage* / Q000627:therapeutic use*; D014859:Warfarin / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D065427:Factor Xa Inhibitors; D011725:Pyridines; D013844:Thiazoles; D014859:Warfarin
references.citation: Lancet. 2015 Jun 6;385(9984):2280-7
references.pmid: 25769357
references.citation: Lancet. 2015 Jun 6;385(9984):2288-95
references.pmid: 25769361